Frau, Roberto <br/><br/>
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.  [electronic resource] 

 -  Experimental neurology  05 2017 
 - 1-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2017.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5-alpha Reductase Inhibitors--therapeutic use<br/>Adrenergic Agents--toxicity<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Benserazide--adverse effects<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Female<br/>Finasteride--therapeutic use<br/>Functional Laterality--drug effects<br/>Levodopa--adverse effects<br/>Male<br/>Oxidopamine--toxicity<br/>Parkinson Disease--drug therapy<br/>Psychomotor Disorders--chemically induced<br/>Rats<br/>Rats, Sprague-Dawley<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism